Company · CIK 1600847
Gamida Cell Ltd.
| CIK | 1600847 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | L3 |
| Business address | Israel |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-02-25 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-253720 | 2021-03-01 | 2024-05-13 | 4 | |
| 333-269181 | 2023-01-11 | 2024-05-13 | 3 | |
| 333-275579 | 2023-11-15 | 2024-05-13 | 3 | |
| 333-259472 | 2021-09-13 | 2023-04-20 | 7 | |
| 333-234701 | 2019-11-14 | 2020-12-18 | 6 | |
| 333-232302 | 2019-06-24 | 2019-06-28 | 4 | |
| 333-227601 | 2018-09-28 | 2018-10-30 | 4 |
Filings
34| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-05-13 | EFFECTDeclared effective | 333-275579 | 9999999995-24-001509 |
| 2024-05-13 | EFFECTDeclared effective | 333-269181 | 9999999995-24-001502 |
| 2024-05-13 | EFFECTDeclared effective | 333-253720 | 9999999995-24-001498 |
| 2023-12-14 | EFFECTDeclared effective | 333-275579 | 9999999995-23-003624 |
| 2023-11-15 | S-3Shelf registered | 333-275579 | 0001213900-23-087635 |
| 2023-04-20 | 424B5Shelf takedown | 333-259472 | 0001213900-23-031376 |
| 2023-04-19 | 424B5Shelf takedown | 333-259472 | 0001213900-23-030828 |
| 2023-01-20 | EFFECTDeclared effective | 333-269181 | 9999999995-23-000149 |
| 2023-01-11 | S-3Shelf registered | 333-269181 | 0001213900-23-002257 |
| 2022-09-29 | 424B5Shelf takedown | 333-259472 | 0001213900-22-060191 |
| 2022-09-27 | 424B5Shelf takedown | 333-259472 | 0001213900-22-059467 |
| 2022-06-03 | EFFECTDeclared effective | 333-253720 | 9999999995-22-001679 |
| 2022-04-01 | EFFECTDeclared effective | 333-259472 | 9999999995-22-000801 |
| 2021-09-21 | EFFECTDeclared effective | 333-259472 | 9999999995-21-003612 |
| 2021-09-13 | F-3Shelf registered | 333-259472 | 0001213900-21-047491 |
| 2021-03-10 | EFFECTDeclared effective | 333-253720 | 9999999995-21-000900 |
| 2021-03-01 | F-3Shelf registered | 333-253720 | 0001213900-21-012567 |
| 2020-12-18 | 424B5Shelf takedown | 333-234701 | 0001213900-20-043488 |
| 2020-12-17 | 424B5Shelf takedown | 333-234701 | 0001213900-20-043183 |
| 2020-05-20 | 424B5Shelf takedown | 333-234701 | 0001213900-20-013082 |
| 2020-05-18 | 424B5Shelf takedown | 333-234701 | 0001213900-20-012807 |
| 2019-11-27 | EFFECTDeclared effective | 333-234701 | 9999999995-19-002687 |
| 2019-11-14 | F-3Shelf registered | 333-234701 | 0001213900-19-023541 |
| 2019-06-28 | 424B4Final prospectus | 333-232302 | 0001140361-19-011945 |
| 2019-06-26 | EFFECTDeclared effective | 333-232302 | 9999999995-19-001454 |
| 2019-06-26 | F-1/AAmendment | 333-232302 | 0001140361-19-011535 |
| 2019-06-24 | F-1Registration filed | 333-232302 | 0001140361-19-011438 |
| 2019-02-15 | DRSDraft made public | 377-02521 | 0001140361-19-003384 |
| 2018-10-30 | 424B4Final prospectus | 333-227601 | 0001140361-18-041581 |
| 2018-10-26 | EFFECTDeclared effective | 333-227601 | 9999999995-18-002726 |
| 2018-10-17 | F-1/AAmendment | 333-227601 | 0001140361-18-040749 |
| 2018-09-28 | F-1Registration filed | 333-227601 | 0001140361-18-039574 |
| 2018-06-01 | DRSDraft made public | 377-02095 | 0001140361-18-026660 |
| 2014-03-06 | DRSDraft made public | 377-00508 | 0001178913-14-000868 |